Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Neurology|September 26, 2014
Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET studyGabriel H Robert, Florence Le Jeune, Clement Lozachmeur, et al.NPJ Parkinson'S Disease|November 3, 2023
Overview on wearable sensors for the management of Parkinson's diseaseCaroline Moreau, Tiphaine Rouaud, David Grabli, et al.Plos One|October 9, 2015
Reduced Verbal Fluency following Subthalamic Deep Brain Stimulation: A Frontal-Related Cognitive Deficit?Jean-François Houvenaghel, Florence Le Jeune, Thibaut Dondaine, et al.Journal of Neurology|April 10, 2016
Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort studySophie Drapier, Alexandre Eusebio, Bertrand Degos, et al.NPJ Parkinson'S Disease|March 27, 2023
Symptoms assessment and decision to treat patients with advanced Parkinson's disease based on wearables dataClara Virbel-Fleischman, Flavien Mousin, Shuo Liu, et al.Movement Disorders Clinical Practice|August 28, 2023
Night-Time Apomorphine Infusion: Who Are the Best Candidates?Valérie Cochen De Cock, Pauline Dodet, Smaranda Leu-Semenescu, et al.Movement Disorders Clinical Practice|April 20, 2026
Continuous Apomorphine Infusion in Multiple System Atrophy Real-World Insights From a French Nationwide Retrospective CohortSimon Lamy, Frederique Leh, Alexandra Foubert-Samier, et al.Parkinsonism & Related Disorders|May 24, 2025
A delphi consensus statement about French practical management of continuous apomorphine infusion in patients with Parkinson's disease and motor fluctuationsFabienne Ory Magne, Sophie Drapier, Ana-Raquel Marques, et al.Neuroimage. Reports|June 26, 2025
Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insulaKarel Joineau, Mathilde Boussac, Patrice Peran, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2024
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA TrialChristine Brefel-Courbon, Estelle Harroch, Ana Marques, et al.Pageof 9